Tesamorelin

Description

Tesamorelin For Sale — Research Peptide

Tesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH) that stimulates the pituitary gland to produce and release growth hormone. It is one of the most extensively studied GHRH analogues, with an FDA-approved form (Egrifta) for HIV-associated lipodystrophy — making it one of the few research peptides with substantial human clinical trial data.

Research Profile

Clinical research on tesamorelin has documented significant reductions in visceral adipose tissue (VAT), improvements in lipid profiles, and effects on GH/IGF-1 axis regulation. Researchers have also studied tesamorelin in the context of cognitive function, non-alcoholic fatty liver disease, and body composition in aging populations. Its well-characterized pharmacokinetic profile makes it a valuable reference compound in GHRH biology research.

Product Specifications

• Compound: Tesamorelin acetate
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder
• Testing: Third-party Certificate of Analysis available
• Storage: -20°C lyophilized; 4°C after reconstitution, use within 28 days
• For laboratory and research use only — not for human consumption

For research and laboratory use only. Not intended for human consumption.